NovaBone received FDA approval for the NovaBone MacroFORM MIS Delivery System designed for minimally invasive orthopedic procedures.
Here are five things to know:
1. The system was developed for surgeons requiring controlled and precise delivery of bone grafting material to surgical sites that aren't readily accessible.
2. The system allows surgeons to deliver bone marrow aspirate to a graft housed in a closed, ready to use minimally invasive cannula.
3. NovaBone released six new collagen products in the last 12 months based on the company's regenerative medicine technology and core competencies in designing innovative and cost-effective medical devices.
4. NovaBone's MacroFORM technology offers bioactivity and is available in multiple formulations and delivery options.
5. NovaBone is a privately-held company based in Florida.